Navigation Links
ABR-Affinity BioReagents to Participate in the American Association for Cancer Research Meeting in San Diego, California, April 12 - 16, 2008
Date:4/11/2008

DENVER, and GOLDEN, Colo., April 11 /PRNewswire/ -- ABR-Affinity BioReagents, a leading global antibody manufacturer, announced today its continued support for the American Association for Cancer Research (AACR) and will exhibit at the annual meeting taking place at the San Diego Convention Center, April 12 - 16, 2008.

"The AACR meeting is a highlight of the year for ABR as we devote a significant portion of our corporate resources to supporting biological research in this critically important area," said Ken Wilczek, President of ABR-Affinity BioReagents. ABR's product portfolio includes over 3,000 quality guaranteed cancer biology antibodies. "Attendance at this meeting affords us the opportunity to enhance our understanding of what today's researchers are focusing on in terms of potential targets and timelines. Each year there are an increasing number of significant developments contributing to extraordinary advances in cancer-related disease research. This is just a great forum in which to interact on a personal level with a cross section of the top life science researchers in the U.S. and around the world. We derive much of our strategic direction from this type of input," finished Mr. Wilczek.

ABR-Affinity BioReagents will be launching 7,500 new products at the meeting across a selection of research areas including: Apoptosis; Cancer Biology; Heat Shock Protein; Ion Transport/Regulation; Neurobiology; Signal Transduction; Transcription Regulation; and Vision.

ABR will be located at booth #820 at next week's meeting in San Diego.

About ABR-Affinity BioReagents

Founded in 1989 with world headquarters in Golden, Colorado, ABR-Affinity BioReagents is a world leader in the manufacture and distribution of monoclonal and polyclonal antibodies, kits, recombinant proteins, siRNA, and custom antibody production services, known as Antibody on Demand(R).

With more than 35,000 antibodies focused in 43 research areas, ABR off
'/>"/>

SOURCE ABR-Affinity BioReagents
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. ABR-Affinity BioReagents Announces Agreements for U.S. Distribution of Research Antibodies
2. ABR-Affinity BioReagents to Exhibit at ASCB in Washington D.C., December 1 - 5, 2007
3. ABR-Affinity BioReagents Finalizes Agreement for Distribution of Osenses Antibodies in the U.S., Canada and Europe
4. ABR-Affinity BioReagents to Exhibit at the Society for Biomolecular Sciences in St. Louis, April 6 - 10, 2008
5. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
6. Boston Scientific to Participate in the Bear Stearns 20th Annual Healthcare Conference
7. China Medical Technologies to Participate in Credit Suisses 2007 Asian Technology Conference
8. Angiotech to participate in UBS Global Life Sciences Conference
9. Transcept Pharmaceuticals to Participate in Middle-of-the-Night (MOTN) Insomnia Investor Panel
10. Vicus Therapeutics Chief Executive Officer to Participate in BIOTECH 2007 Expert Panels
11. Genzyme to Participate in FDA Advisory Committee Meeting on the Use of Phosphate Binders in Chronic Kidney Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... May 22, 2013 Cambridge Semantics ... last week’s “Data Demonstration Day” on Capitol Hill, hosted by ... EMC, Google, Microsoft and others to showcase how innovative data ... Accountability and Transparency Act (DATA Act). , Originally introduced in ... (R-CA) and Sen. Mark Warner (D-VA ), ...
(Date:5/22/2013)... (PRWEB) May 22, 2013 The ... Annual Disruptive Innovations to Advance Clinical Trials conference taking ... Hotel in Boston, MA. , Disruptive thinkers from ... and more share bold approaches to reduce expensive infrastructure, ... “Disruptive innovation needs to be big, or novel, or ...
(Date:5/22/2013)... 2013   Oligomerix, Inc. , a privately ... therapeutics for Alzheimer,s disease (AD) and related neurodegenerative ... B financing, which includes both issuance of new ... approximately $2.8M in new investments in the Company.  ... raise. Funding from the Series ...
(Date:5/22/2013)... 2013  Empire Genomics announced today it has ... novel genomic biomarker from Cornell University for use ... help in diagnosing and determining treatment for patients ... Neuroendocrine prostate cancer (NEPC) is a lethal variant ... novo, but more commonly arises after hormonal therapy ...
Breaking Biology Technology:Cambridge Semantics Underscores Need for Smart Data during “Data Demonstration Day” on Capitol Hill 2Disruptive Innovation Hits Clinical Trials, Dedicated Event Launches 2Oligomerix, Inc. Completes Series B Financing 2Oligomerix, Inc. Completes Series B Financing 3Empire Genomics Licenses Novel DNA Biomarker for Use in Diagnosing and Creating a Companion Diagnostic Test for Neuroendocrine Prostate Cancer 2
... Wisconsin businesses and individuals are invited ... Awards Competition, which recognizes benefits coming from research ... , ,Governor's New Products Awards are given ... more employees); large companies (500-999 employees); medium companies ...
... 2003, I wrote on an article on "The Final Death ... was on the walls of the demise of Searle due ... remaining Searle facilities in Chicago. Since then, the Searle name ... to another article I wrote on May 16, 2005, titled ...
... about $400,000 worth of software to Lad Lake ... their families. Rob Busch, enterprise sales manager for Microsoft ... non-profit's Synergy School in Milwaukee for the formal announcement. ... Lad Lakes network and software infrastructure, including the computers ...
Cached Biology Technology:Searle spirit lives on in Chicago as alumni celebrate at former home 2Searle spirit lives on in Chicago as alumni celebrate at former home 3Searle spirit lives on in Chicago as alumni celebrate at former home 4Searle spirit lives on in Chicago as alumni celebrate at former home 5
(Date:5/22/2013)... The feared Legionella pneumophila bacteria is responsible ... pneumonia. In order to infect us, this pathogen has ... and go unnoticed in our cells, thus avoiding these ... the Basque biosciences research centre, CIC bioGUNE, in which ... the USA and the National Supercomputation Centre in Barcelona ...
(Date:5/22/2013)... how climate change will affect interactions between species in ... of Animal Ecology . This knowledge, they say, is ... how species are likely to be impacted by rising ... among biologists that climate change is affecting how species ... to have very important consequences for the stability and ...
(Date:5/22/2013)... Calif., May 22, 2013 Early screening for prostate ... pregnancy testing is for women, thanks to UC Irvine ... American Chemical Society . , After more than a ... way to clearly identify clinically usable markers for prostate ... detected far sooner, with greater accuracy and at dramatically ...
Breaking Biology News(10 mins):Mechanism discovered which aids Legionella to camouflage itself in the organism 2UCLA life scientists present new insights on climate change and species interactions 2UCLA life scientists present new insights on climate change and species interactions 3UCLA life scientists present new insights on climate change and species interactions 4UCLA life scientists present new insights on climate change and species interactions 5UCI chemists devise inexpensive, accurate way to detect prostate cancer 2UCI chemists devise inexpensive, accurate way to detect prostate cancer 3
... of white blood cell types may help physicians ... and bacterial tonsillitis, potentially guiding treatment decisions, according ... Archives of Otolaryngology–Head & Neck Surgery, one of ... the tonsils) and infectious mononucleosis (caused by the ...
... has found evidence of the Earth's earliest forest trees, dating ... were uncovered after a flash flood in Gilboa, upstate New ... has known what the entire trees looked like. , ... trees which had fallen sideways, with their trunk, branches, twigs ...
... the University of Pennsylvania School of Medicine have discovered ... down a protein that is defective in cystic fibrosis ... from lung cells to airways causes thick mucus to ... therapeutic target for treating lung infections in some cystic ...
Cached Biology News:Common blood test can help distinguish between mononucleosis and tonsillitis 2Penn study on lung-infecting bacterial enzyme suggests new approach to cystic fibrosis treatment 2
Lyophilized. Purity: ≥90% by electrophoresis. Reconstitute in 0.3% NaCl. Prepared from serum that has been shown by certified tests to be negative for HBsAg and for HIV and HCV antibodies. ...
PP2B-Abeta (C-20)...
Goat polyclonal to Duffy / FY / DARC...
... Source: Tritirachium album Description: ... endopeptidase used in a wide range of applications ... peptide bonds mainly following the carboxyl group of ... and is classified as a serine protease. ...
Biology Products: